Why the study?
Does intracoronary infusion of 8-azaguanine and adenine enhance myocardial reactive hyperaemia following brief coronary occlusions in an anaesthetised open-chest dog model?
Does intracoronary infusion of 8-azaguanine and adenine enhance myocardial reactive hyperaemia following brief coronary occlusions in an anaesthetised open-chest dog model?
Adenosine deaminase inhibitors enhance myocardial reactive hyperaemia following brief coronary occlusions in a canine model, likely by inhibiting adenosine degradation.
May enhance reactive hyperemia in canine models; leaves open translation to human coronary physiology.
Effect of two agents of adenosine deaminase inhibitor, 8-azaguanine and adenine, on myocardial reactive hyperaemia was tested in the anaesthetised open-chest dog. Reactive hyperaemic flow response of the circumflex coronary artery was observed following 5, 10, 15, 20 and 30 s coronary occlusions before, during and after infusion of 8-azaguanine and adenine, which are known as adenosine deaminase inhibitors. Intracoronary infusion of 8-azaguanine and adenine caused the minimum increase in the baseline coronary flow. Both the nucleic acids shifted the dose response curve of adenosine to the left. 8-azaguanine enhanced volume response of flow at all occlusion intervals tested. The infused dose of adenine also intensified volume response of flow after 5, 15, 20 and 30 s occlusions. Fifteen minutes after termination of the nucleic acid infusions, the reactive hyperaemia returned towards control levels. The results suggest that 8-azaguanine and adenine enhance myocardial reactive hyperaemia possibly by inhibiting adenosine deaminase to degradate myocardial interstitial adenosine to inosine.
No takes yet. Share an insight, caveat, or question.
Saito et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: